EE85 Cost-Effectiveness Analysis of GAAD Algorithm on the Detection of Early-Stage Hepatocellular Carcinoma in Patients With Chronic Liver Disease in China

When clinically diagnosed as hepatocellular carcinoma in China, 70%-80% of patients are late-stage along with high treatment costs. Several diagnostic strategies are employed but the detection of early-stage HCC is still limited. The emerging GAAD algorithm has demonstrated better performance on early-stage HCC detection, whereas its cost-effectiveness in China is unclear.